Abbott Laboratories (ABT) Long-Term Investments (2009 - 2026)
Abbott Laboratories (ABT) posted Long-Term Investments of $1.1 billion for Q2 2026, up 1.93% sequentially from $1.1 billion in Q1 2026, and up 15.97% YoY from $958.0 million in Q2 2025.
Abbott Laboratories (ABT) Long-Term Investments (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Long-Term Investments for 18 years, with the latest figure at $1.1 billion in Q2 2026.
- Quarterly Long-Term Investments rose 15.97% year-over-year to $1.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.1 billion (up 15.97% YoY) and the FY2025 annual result came in at $918.0 million, up 3.61% from the prior year.
- Long-Term Investments rose to $1.1 billion in Q2 2026 per ABT's latest filing, from $1.1 billion in the prior quarter.
- Over five years, Long-Term Investments peaked at $1.1 billion in Q2 2026 and troughed at $734.0 million in Q2 2022.
- A 5-year average of $867.6 million and a median of $847.5 million in 2024 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2022 and 2026: Long-Term Investments decreased 8.82% in 2022, then grew 20.18% in 2026.
- Over 5 years, Long-Term Investments stood at $766.0 million in 2022, then gained by 4.31% to $799.0 million in 2023, then climbed by 10.89% to $886.0 million in 2024, then gained by 3.61% to $918.0 million in 2025, then gained by 21.02% to $1.1 billion in 2026.
- According to Business Quant data, Long-Term Investments over the past three periods registered $1.1 billion, $1.1 billion, and $918.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 2.25 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 244.10 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 175.52 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 19.21 Bn | 18.80 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.11 Bn |
| Mar 31, 2026 | 1.09 Bn |
| Dec 31, 2025 | 918.00 Mn |
| Sep 30, 2025 | 951.00 Mn |
| Jun 30, 2025 | 958.00 Mn |
| Mar 31, 2025 | 907.00 Mn |
| Dec 31, 2024 | 886.00 Mn |
| Sep 30, 2024 | 912.00 Mn |
| Jun 30, 2024 | 877.00 Mn |
| Mar 31, 2024 | 818.00 Mn |
| Dec 31, 2023 | 799.00 Mn |
| Sep 30, 2023 | 788.00 Mn |
| Jun 30, 2023 | 799.00 Mn |
| Mar 31, 2023 | 776.00 Mn |
| Dec 31, 2022 | 766.00 Mn |
| Sep 30, 2022 | 764.00 Mn |
| Jun 30, 2022 | 734.00 Mn |
| Mar 31, 2022 | 763.00 Mn |
| Dec 31, 2021 | 816.00 Mn |
| Sep 30, 2021 | 812.00 Mn |